000 | 05729cam a2200505 i 4500 | ||
---|---|---|---|
001 | on1285779191 | ||
003 | OCoLC | ||
005 | 20230516170002.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 211120s2022 ne o 000 0 eng d | ||
040 |
_aEBLCP _beng _erda _epn _cEBLCP _dYDX _dYDXIT _dN$T _dOCLCQ _dOPELS _dOCLCO _dAMH _dOCLCQ |
||
019 |
_a1285452207 _a1285494784 |
||
020 |
_a0128226714 _q(electronic book) |
||
020 |
_a9780128226711 _q(electronic bk.) |
||
020 | _z0128194693 | ||
020 | _z9780128194690 | ||
035 |
_a(OCoLC)1285779191 _z(OCoLC)1285452207 _z(OCoLC)1285494784 |
||
050 | 4 |
_aR857.M3 _bN35 2022eb |
|
082 | 0 | 4 |
_a610.284 _223 |
245 | 0 | 0 |
_aNanotechnology in medicine and biology / _cedited by Huinan H. Liu, Tolou Shokuhfar, Sougata Ghosh. |
264 | 1 |
_aAmsterdam, Netherlands ; _aOxford, United Kingdom ; _aCambridge, MA : _bElsevier, _c[2022] |
|
300 | _a1 online resource (296 pages) | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
490 | 1 | _aElsevier Series on Advanced Topics in Biomaterials | |
505 | 0 | _aIntro -- Nanotechnology in Medicine and Biology -- Copyright -- Contents -- Contributors -- Preface -- Chapter 1 Nanobiomaterials for three-dimensional bioprinting -- 1.1 Introduction -- 1.2 Inkjet bioprinting -- 1.3 Bioplotting -- 1.4 Fused-deposition modeling -- 1.5 Selective laser sintering -- 1.6 Stereolithography -- 1.7 3D printing for complex tissue and organ regeneration -- 1.7.1 Bone -- 1.7.2 Cartilage and osteochondral tissue -- 1.7.3 Neural tissue -- 1.7.4 Vascular tissue -- 1.7.5 Organs -- 1.8 4D printing -- 1.9 Conclusion and future perspectives -- Acknowledgments | |
504 | _aReferences-Chapter 2 Nanobiomaterials for drug delivery and theranostics-2.1 Introduction-2.2 Design parameters of nanomedicine for drug delivery and theranostics-2.3 Targeted drug delivery for cancer therapy-2.3.1 Passive targeting-2.3.2 Active targeting-2.3.2.1 Tumor cell targeting-2.3.2.2 Vascular targeting (anti-angiogenesis)-2.4 Toxicity of nanobiomaterials-2.5 Biodegradable nanomaterials used in controlled drug delivery and imaging-2.5.1 Organic and polymer-based nanocarriers-2.5.1.1 Liposomes-2.5.1.2 Biodegradable polymer-based nanocarriers. | ||
505 | 8 | _a2.5.1.3 Dendrimers -- 2.5.2 Inorganic nanobiomaterials for drug delivery and imaging -- 2.5.2.1 Carbon-based nanomaterials -- i) Fullerenes -- ii) Carbon nanotubes -- iii) Graphene and graphene oxide -- 2.5.2.2 Gold nanoparticles -- 2.5.2.3 Magnetic nanoparticles -- 2.5.2.4 Quantum dots -- 2.5.2.5 Mesoporous silica nanoparticles -- 2.6 Conclusion and future perspectives -- References -- Chapter 3 Nanobiomaterials in hard tissue repair -- 3.1 Introduction -- 3.2 Biomaterials in hard tissue engineering -- 3.2.1 Problems in biomaterials -- 3.2.2 Why nanobiomaterials are a potential solution? | |
505 | 8 | _a3.3 Nanobiomaterials in tissue engineering -- 3.3.1 Polymeric nanobiomaterials -- 3.3.1.1 Polymers of natural origin -- 3.3.1.2 Synthetic polymers -- 3.3.2 Ceramic nanobiomaterials -- 3.3.2.1 Bioceramics -- 3.3.2.2 Bioglass: Bioactive ceramic materials -- 3.3.3 Metallic nanobiomaterials -- 3.3.4 Nanobiomaterials from carbon -- 3.3.5 Nanobiomaterial composites -- 3.4 Role of stem cells -- 3.5 Conclusion and future perspectives -- References -- Chapter 4 Application of nanobiomaterials in soft tissue engineering -- 4.1 Introduction -- 4.2 Tissue engineering | |
505 | 8 | _a4.2.1 Nanotechnology in scaffold designing -- 4.2.2 Nanobiomaterials in soft tissue regeneration -- 4.3 Nanobiomaterials in cartilage tissue engineering -- 4.3.1 Cartilage tissue -- 4.3.2 Rationale for cartilage tissue engineering -- 4.3.3 Cartilage tissue engineering -- 4.3.4 Nanobiomaterials in cartilage tissue engineering -- 4.3.4.1 Nanofibers in cartilage tissue engineering -- 4.3.4.2 Nanocomposites in cartilage tissue engineering -- 4.4 Nanobiomaterials in tendon/ligament tissue engineering -- 4.4.1 Tendon/ligament tissue -- 4.4.2 Rationale for tendon/ligament tissue engineering | |
500 | _a4.4.3 Nanobiomaterials in tendon/ligament tissue engineering. | ||
588 | 0 | _aOnline resource; title from digital title page (viewed on December 30, 2021). | |
520 | _aNanotechnology in Medicine and Biology brings together a multidisciplinary team of experts from the fields of materials science, nanotechnology, medicine and biomedical engineering to introduce new nanoscale biomaterials and their applications, diagnosis and treatment of disorders of the human body. The book presents the fundamentals for understanding the design, properties and selection of nanobiomaterials as well as their real-world applications in medicine. Each chapter addresses current regulations, manufacturing processes, and translation issues of nanobiomaterials for key applications. A discussion of current protocols and their benefits and disadvantages is also included. This book provides comprehensive background and knowledge in the field of nanobiomaterials that is suitable for academics, scientists and clinicians. | ||
650 | 0 |
_aBiomedical materials _xTechnological innovations. _969669 |
|
650 | 6 |
_aBiomat�eriaux _0(CaQQLa)201-0025723 _xInnovations. _0(CaQQLa)201-0379286 _969670 |
|
700 | 1 |
_aLiu, Huinan, _eeditor. _969671 |
|
700 | 1 |
_aShokuhfar, Tolou, _eeditor. _969672 |
|
700 | 1 |
_aGhosh, Sougata, _eeditor. _969673 |
|
776 | 0 | 8 |
_iPrint version: _aLiu, Huinan. _tNanotechnology in Medicine and Biology. _dSan Diego : Elsevier, �2021 _z9780128194690 |
830 | 0 |
_aElsevier Series on Advanced Topics in Biomaterials _969674 |
|
856 | 4 | 0 |
_3ScienceDirect _uhttps://www.sciencedirect.com/science/book/9780128194690 |
942 | _cEBK | ||
999 |
_c82660 _d82660 |